IL6 and T-cell non-Hodgkin lymphoma: In summary, the loss of IL-6 in ∆122/∆122 mice resulted in decreased levels of serum cytokines and chemokines involved in the JAK-STAT pathway and significantly decreased the incidence of T-cell lymphomas with extensive spread.